All In MedTech

Device Trial Radar · NCT07941024

H.A.L.T. MAX Spectacle Lenses for High Myopia Control

Clinical Study on Efficacy and Safety of H.A.L.T. MAX Spectacle Lenses for High Myopia Control in Children and Adolescents

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

112

Planned (sponsor's estimate)

Start

Nov 15, 2026

Primary completion

May 15, 2029

Study completion May 15, 2029

Sponsor

Lead sponsor
Shanghai Eye Disease Prevention and Treatment CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Nov 17, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 7 years, up to 14 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is intended to focus on children aged 7-14 years with high myopia and to use a 2-year, single-arm, prospective design in which participants wear H.A.L.T. MAX lenses for at least 12 hours per day for 2 consecutive years. By comparing changes in refractive error and other indicators, the study will evaluate the efficacy, safety, and wearing compliance of H.A.L.T. MAX lenses in delaying myopia progression in children with high myopia, thereby providing scientific evidence for public health efforts to delay myopia progression in highly myopic populations and for the formulation and implementation of programs to address the risk of blindness and visual impairment caused by high myopia.

Conditions

  • High Myopia

Interventions

  • H.A.L.T. MAX spectaclesDevice

    Wearing H.A.L.T. MAX spectacles for at least 12 hours a day over 2 years.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. SER changeTime frame: 2 years

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.